Synthesis, kinetics, binding conformations and structure-activity relationship of potent tyrosinase inhibitors: Aralkylated 2-aminothiazole-ethyltriazole hybrids

Considering the diversified pharmacological importance of thiazole and triazole heterocyclic moieties, a unique series of S-aralkylated bi-heterocyclic hybrids, 7a-l, was synthesized in a convergent manner. The structures of newly synthesized compounds were characterized by 1 H-NMR,13C-NMR, IR, and...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Iranian Journal of Pharmaceutical Research
المؤلف الرئيسي: 2-s2.0-85111424369
التنسيق: مقال
اللغة:English
منشور في: Iranian Journal of Pharmaceutical Research 2021
الوصول للمادة أونلاين:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111424369&doi=10.22037%2fijpr.2020.15521.13145&partnerID=40&md5=fac8f033ad621c698eed9be97fe4926b
الوصف
الملخص:Considering the diversified pharmacological importance of thiazole and triazole heterocyclic moieties, a unique series of S-aralkylated bi-heterocyclic hybrids, 7a-l, was synthesized in a convergent manner. The structures of newly synthesized compounds were characterized by 1 H-NMR,13C-NMR, IR, and EI-MS spectral studies. The structure-activity relationship of these compounds was envisaged by analyzing their inhibitory effects against tyrosinase, whereby all these molecules exhibited potent inhibitory potentials relative to the standard used. The Kinetics mechanism was ascertained by Lineweaver-Burk plots, which revealed that 7g inhibited tyrosinase non-competitively by forming an enzyme-inhibitor complex. The inhibition constants Ki calculated from Dixon plots for this compound was 0.0057µM. These bi-heterocyclic molecules also disclosed good binding energy values (kcal/mol) when assessed computationally. So, these molecules can be considered promising medicinal scaffolds for the treatment of skin disorders. © 2021, Iranian Journal of Pharmaceutical Research. All rights reserved.
تدمد:17350328
DOI:10.22037/ijpr.2020.15521.13145